Missed a dose?
Don't worry!

You can take your
Rhopressa® the
next day

Common Questions

Everything you need to know about Rhopressa®.
All in one place.

What is Rhopressa®?

Rhopressa® (netarsudil ophthalmic solution) 0.02% is a new FDA-approved prescription eye drop used for the treatment of elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

How often do I take Rhopressa®?

Rhopressa® should only be taken once a day, at night. Do not administer Rhopressa® more than once a day.

Can I use Rhopressa® with other eye drop medications?

When Rhopressa® is used with another medication, it is recommended to wait at least 5 minutes. Please consult with your doctor if you have specific questions or concerns about any medications you're currently taking.

Are there any possible side effects I should know about Rhopressa®?

The most common side effect of Rhopressa® was eye redness. Other common side effects included corneal deposits (verticillata), eye pain, irritation upon instillation, and a red spot on the white of the eye. These are not all of the possible side effects of Rhopressa®.

How do I store Rhopressa®?

Rhopressa® may be stored at room temperature (36°F to 77°F) for up to 6 weeks.

To prevent contamination of the solution, avoid touching the tip of the container to the eyes, fingers, or any surface. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.

Are there any financial assistance options for Rhopressa®?

Rhopressa® offers a savings card that helps eligible patients with commercial insurance save on their out-of-pocket costs. Learn more about the Rhopressa® Savings Card.

Jump-start the conversation at your next eye appointment

If you're not sure where to start, use the questions below to help guide the conversation during your next eye appointment

  • 1Are there any new treatments that I can add to my existing glaucoma or ocular hypertension treatment?
  • 2What makes Rhopressa® different from other glaucoma or ocular hypertension medications?
  • 3Is it true that Rhopressa® can be used with any other eye drop medications I may be taking?
  • 4Would a once-daily prescription eye medication like Rhopressa® be beneficial for me?
  • 5Are there any possible side effects I should be aware of while taking Rhopressa®?

Download the Rhopressa® Savings Card today!

It's a quick and easy way to help eligible patients save on their out-of-pocket costs!

IMPORTANT SAFETY INFORMATION

Dosage and Administration: Twice a day dosing is not well tolerated and is not recommended. If RHOPRESSA® is to be used concomitantly with other topical ophthalmic drug products to lower IOP, administer each drug product at least 5 minutes apart.

+

IMPORTANT SAFETY INFORMATION

Dosage and Administration: Twice a day dosing is not well tolerated and is not recommended. If RHOPRESSA® is to be used concomitantly with other topical ophthalmic drug products to lower IOP, administer each drug product at least 5 minutes apart.

Warnings and Precautions:

Bacterial Keratitis - There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products. These containers had been inadvertently contaminated by patients who, in most cases, had a concurrent corneal disease or a disruption of the ocular epithelial surface.

Adverse reactions: The most common ocular adverse reaction observed in controlled clinical studies with RHOPRESSA® dosed once daily was conjunctival hyperemia which was reported in 53% of patients. Other common (approximately 20%) adverse reactions were: corneal verticillata, instillation site pain, and conjunctival hemorrhage. Instillation site erythema, corneal staining, blurred vision, increased lacrimation, erythema of eyelid, and reduced visual acuity were reported in 5-10% of patients.

The corneal verticillata seen in RHOPRESSA®-treated patients were first noted at 4 weeks of daily dosing. This reaction did not result in any apparent visual functional changes in patients. Most corneal verticillata resolved upon discontinuation of treatment.

INDICATION

RHOPRESSA® (netarsudil ophthalmic solution) 0.02% is a Rho kinase inhibitor indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Dosage and Administration: The recommended dosage is one drop in the affected eye(s) once daily in the evening.